# FDA Inspection 1251711 - Alpex Pharma SA - December 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/alpex-pharma-sa/d1084fe2-643b-4b4c-9432-3db0d2f6485a
Source feed: FDA_Inspections

> FDA Inspection 1251711 for Alpex Pharma SA on December 14, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251711
- Company Name: Alpex Pharma SA
- Inspection Date: 2023-12-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 943788 - 2015-08-21](https://www.keypedia.com/records/fda_inspections/alpex-pharma-sa/8b0d0680-7a1b-4665-a745-36c70f45bea2)
- [FDA Inspection 711917 - 2011-02-24](https://www.keypedia.com/records/fda_inspections/alpex-pharma-sa/3da6ce60-225e-419b-bd9d-8ffb3073a974)

Company: https://www.keypedia.com/companies/alpex-pharma-sa/28364706-78cf-4965-a842-398e86581a3a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c